Interventional Cardiology

Terumo Corporation announced that it has received CE mark approval for its drug-eluting stent, “Ultimaster”, with features expected to reduce stent thrombosis and to produce favourable long term clinical outcomes.

Long-term outcomes in women with unprotected left main coronary artery disease (CAD) are comparable whether they receive percutaneous coronary intervention (PCI) with drug-eluting stents (DES) or coronary artery bypass grafting (CABG), according to a registry study published online February 3, 2014, ahead of print in the American Journal of Cardiology. However, CABG was associated with less long-term target vessel revascularization (TVR) and target lesion revascularization (TLR).

We report on a patient treated with a drug-coated balloon (DCB) for recurrent in-stent restenosis (ISR) who at late follow-up developed NA as depicted by OCT and IVUS.

Coronary heart disease can result in the blockage of arteries. Insertion of a stent can open up the clogged artery. The blockage can re-form but this re-blockage can be inhibited if the stent is coated with a chemotherapy drug.

It’s been over 35 years since the first angioplasty was performed in Zurich by Dr. Andreas Gruentzig, but it was just yesterday that this minimally invasive procedure arrived in Australia’s Northern Territory.

A new-generation zotarolimus-eluting stent (ZES) continues to show strong safety and efficacy outcomes similar to those of a second-generation everolimus-eluting stent (EES) at 4 years in ‘real world’ coronary artery disease (CAD) patients, according to a study published online February 12, 2014, ahead of print in the Journal of the American College of Cardiology. Moreover, target lesion revascularization (TLR) accounts for less than half of all revascularizations after the index intervention, suggesting that ongoing medical management is as important as initial stent choice, the authors say.

The public health department's crucial decision to negotiate with leading firms to halve the price of drug-eluting stents has helped well over 100 poor patients in just a fortnight.

The US Coronary Stent Industry Outlook to 2018 – Bioabsorbable Stents to Drive the Future Growth” provides a comprehensive analysis of the various aspects such as the market size of the US Coronary Stent industry, market segments i.e. drug eluting and bare metal stents and future outlook of the industry. The report also covers the market share of major players in the US.

Hurley Medical Center is the only medical center in Genesee County and one of six in the state to use a new kind of drug-coated stent, the Zilver PTX drug-eluting peripheral stent designed to treat peripheral artery disease.

Alternatives means of delivering drugs such as paclitaxel could have a similar effect to drug-eluting stents without the invasive procedure, according to a new study to be published in the journal Nanomedicine: Nanotechnology, Biology and Medicine.

SANTA ROSA -- Medtronic, Inc. (NYSE: MDT) on Tuesday reported its Cardiac and Vascular group, which is based in Santa Rosa, reported global sales of $2.119 billion, an increase of 1 percent over the year.
The Minneapolis-based company as a whole, however, reported that its third quarter net profit dropped 23 percent, largely related to the discontinuation of a high blood pressure treatment that failed to make it out of trial.

Interruption of dual antiplatelet therapy (DAPT) in patients with second-generation zotarolimus-eluting stents (ZES) is unlikely to lead to stent thrombosis as long as it occurs at least 1 month after implantation, according to a retrospective study published online February 7, 2014, ahead of print in the European Heart Journal. However, earlier interruption is associated with a high risk of adverse events.